Skip to content Skip to navigation

Tuki moots healthier future

The Arunachal government will cover all uncovered families under the Chief Minister’s Universal Health Insurance Scheme in this financial year for a healthier state by facilitating hassle-free cashless treatment to its citizens in empanelled hospitals.

More reputed and specialized hospitals like Medanta, NEIGRIMS, Apollo, CMC Vellore, Gangaram Hospitals, Ramakrishna Mission, etc are also in the pipeline for government empanelment.

On second day of the second phase of the State Development Council (SDC) meet held under Chief Minister NabamTuki in Itanagar on Wednesday.

Tuki asked the health department to coordinate with the insurance company to take the Universal Health Insurance scheme to those households still uncovered.

The department would facilitate posting of regular insurance company staff at Pasighat and Itanagar for enrolling families under the scheme.

Author info

AT News's picture

Assam Times Staff

Add new comment


Republish this content

Situation at Mazbat tense but under control

25 Dec 2014 - 4:53pm | Jayanta Kumar Das

One person injured seriously yesterday when a group of NDFB(S) sprayed bullets targeting the villagers at Lambari Santhalgaon under Mazbat PS in Udalguri district at about 1 pm. According to reliable sources, one Bishnu Saura(55) sustained two bullet injuries when the ultra group opned indiscriminate fire in the village in the broad daylight. The injured was reported to have been sent to the GMCH for better treatment.

Meanwhile, Adivasi villagers, tea gardeners came out in large number to protest the inhuman killings of villagers in Kokrajhar and Sonitpur district. 62 houses of Adarsha Bahadur gaon and six shops in Naharbari village, all the market sheds in Goshenpur village and a good number of business places at Lamabari market places were burnt to ashes today under Mazbat PS in Udalguri district. Meanwhile, security forces started patrolling in the disturbed region.


Prodeep Kumar Daimary, president of UDPF reacted sharply to the mass killing of innocent villagers and termed it as a preplanned nasty design of the NDFB(S) to derail the ongoing peace process of NDFB(Progressive) with the government. A prèss release of Udalguri district committee of Bodoland Students’ Union (BSU) also condemned the violent and inhuman activities of the ultra outfit and demanded to solve the ongoing problem of the NDFB at the earliest. The press release also appealed all to be alert and restrain temper for the interest of peace. 

Will India reaffirm commitment to TB/HIV in New York?

4 Jun 2008 - 7:36pm | bobbyramakant
On June 9, for the first-time government, public health and business leaders, heads of UN agencies and advocates are coming together at United Nations (UN) Headquarters to acknowledge HIV/TB as an urgent priority. This first HIV/TB Global Leaders' Forum, convened by Dr Jorge Sampaio, the UN Secretary-General's Special Envoy to Stop TB, seeks to galvanize leadership at all levels.

The 2008 Anti-Tuberculosis Drug Resistance in the World report and the 2008 Global Tuberculosis Epidemic report of World Health Organization (WHO) clearly mandates much heightened urgency in responding to TB-HIV co-infection.

India continues to have the highest TB burden in the world. TB is the leading cause of death among people living with HIV (PLHIV). Approximately one third of the nearly 40 million PLHIV are also infected with TB. In high TB and HIV burden settings, up to 80% of TB patients may be co-infected with HIV and half of AIDS-related deaths are caused by TB.

Without proper treatment with anti-TB drugs, approximately 90% of people living with HIV die within two to three months of becoming sick with TB, even if they are receiving anti-retroviral treatment. Worldwide, nearly a quarter of a million people die from HIV/TB co-infection each year. This dual threat is a barrier to keeping people healthy and productive, and impacts poverty reduction plans and the broader development agenda. However, adequate treatment of TB in PLHIV has shown to prolong their life by at least two years.

HIV weakens the immune system and makes it more likely that latent TB infection progresses to active TB disease. PLHIV are up to 50 times more likely to develop TB disease over their lifetime.

Even where DOTS [directly-observed treatment short-course] programmes are available, current diagnostic tests fail to detect active TB in 60-80% of PLHIV due to the predominantly smear-negative nature of TB in this group.

Studies suggest that transmission of TB, especially the drug-resistant strains is more likely to take place where PLHIV congregate. Healthcare settings, for example anti-retroviral (ARV) clinics, are one such place where improper infection control can put PLHIV at risk of contracting TB. Improving infection control in healthcare settings is clearly vital, doable and potentially life saving.

In many countries insufficient laboratory capacity to test drug-resistance is a serious impediment in scaling up TB programmes. Developing laboratories to provide rapid diagnosis of anti-TB drug-resistance, particularly for PLHIV, is of utmost importance to improve TB responses.

Many countries including India are making impressive gains in treating people living with HIV, but this investment and progress is squandered by a preventable and curable disease: TB.

A number of studies, including one released by the World Bank last month, have found that the direct and indirect costs of inaction on HIV are far greater than the costs of treatment. As for TB, a 2007 World Bank research report clearly demonstrated that countries heavily affected by TB could collect at least 9 times their investments in TB control.

There are well-established approaches for preventing deaths from HIV/TB. PLHIV need to be screened regularly for TB. Those who are sick with TB need effective TB treatment and those without TB disease should receive TB preventive therapy. These treatments are not expensive. A six-month course of TB treatment costs US$ 20; and preventive drug therapy costs US$ 2.

But progress remains slow on the more challenging front of detecting and treating TB among people cared for in HIV treatment settings. In 2006, only 1% of people living with HIV were screened for TB worldwide, according to WHO estimates.

New strategies and tools are urgently needed to tackle the challenge of TB/HIV co-infection. WHO-recommended collaborative TB/HIV activities must be accelerated, and research stepped up to deliver a new generation of effective anti-TB drugs and diagnostics to keep co-infected people alive. Closer coordination between national TB and HIV programmes and services is vital.

Here comes bihu

16 Mar 2014 - 8:09pm | AT News

Syed khairul hassan

Nazira is throbbing with the preparations for the Rongali Bihu these days.

Nazira Traders Association and Nazira Dikhow will observe the Bihu with all pomp and gaiety.

The first day of the new Assamese calendar or the Bor Bihu would be celebrated with day long colourful cultural programme in front of the Nazira Natya Mandir.

This is for the third time the trader body has jointly organized the event in association with the socio cultural organization.